Copeland Capital Management’s Amgen AMGN Stock Holding History

Copeland Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$141K	Hold	400	–	–	﹤0.01%	164
2025 Q4	$131K	Hold	400	–	–	﹤0.01%	164
2025 Q3	$113K	Hold	400	–	–	﹤0.01%	167
2025 Q2	$112K	Hold	400	–	–	﹤0.01%	157
2025 Q1	$125K	Sell	400 -11	-3%	-$3.25K	﹤0.01%	154
2024 Q4	$107K	Hold	411	–	–	﹤0.01%	157
2024 Q3	$132K	Buy	+411	New	+$134K	﹤0.01%	150
2024 Q2	–	Sell	-411	Closed	-$117K	–	152
2024 Q1	$117K	Hold	411	–	–	﹤0.01%	150
2023 Q4	$118K	Hold	411	–	–	﹤0.01%	141
2023 Q3	$110K	Hold	411	–	–	﹤0.01%	145
2023 Q2	$91.3K	Hold	411	–	–	﹤0.01%	148
2023 Q1	$99K	Hold	411	–	–	﹤0.01%	149
2022 Q4	$108K	Hold	411	–	–	﹤0.01%	152
2022 Q3	$93K	Hold	411	–	–	﹤0.01%	152
2022 Q2	$100K	Hold	411	–	–	﹤0.01%	152
2022 Q1	$99K	Hold	411	–	–	﹤0.01%	150
2021 Q4	$92K	Hold	411	–	–	﹤0.01%	151
2021 Q3	$87K	Hold	411	–	–	﹤0.01%	152
2021 Q2	$100K	Hold	411	–	–	﹤0.01%	150
2021 Q1	$102K	Hold	411	–	–	﹤0.01%	152
2020 Q4	$94K	Buy	411 +2	+0.5%	+$461	﹤0.01%	146
2020 Q3	$104K	Hold	409	–	–	﹤0.01%	138
2020 Q2	$96K	Hold	409	–	–	﹤0.01%	137
2020 Q1	$83K	Hold	409	–	–	0.01%	138
2019 Q4	$99K	Hold	409	–	–	﹤0.01%	148
2019 Q3	$79K	Hold	409	–	–	﹤0.01%	146
2019 Q2	$75K	Sell	409 -18,596	-98%	-$3.33M	﹤0.01%	151
2019 Q1	$3.61M	Sell	19,005 -14,424	-43%	-$2.75M	0.23%	96
2018 Q4	$6.51M	Buy	33,429 +249	+0.8%	+$48.6K	0.47%	75
2018 Q3	$6.88M	Sell	33,180 -402	-1%	-$79.2K	0.42%	100
2018 Q2	$6.2M	Sell	33,582 -4,206	-11%	-$744K	0.36%	98
2018 Q1	$6.44M	Buy	37,788 +2,074	+6%	+$381K	0.41%	95
2017 Q4	$6.21M	Sell	35,714 -1,115	-3%	-$197K	0.39%	95
2017 Q3	$6.87M	Sell	36,829 -6,291	-15%	-$1.11M	0.47%	82
2017 Q2	$7.43M	Sell	43,120 -12,670	-23%	-$2.06M	0.49%	89
2017 Q1	$10.1M	Buy	55,790 +9,735	+21%	+$1.62M	0.7%	69
2016 Q4	$6.73M	Buy	46,055 +29,387	+176%	+$4.42M	0.44%	88
2016 Q3	$2.78M	Sell	16,668 -687	-4%	-$116K	0.18%	112
2016 Q2	$2.64M	Sell	17,355 -392	-2%	-$60.9K	0.18%	108
2016 Q1	$2.66M	Sell	17,747 -62	-0.3%	-$9.21K	0.18%	108
2015 Q4	$2.89M	Sell	17,809 -123,568	-87%	-$19.4M	0.16%	110
2015 Q3	$19.6M	Buy	141,377 +39,848	+39%	+$6.28M	1.2%	35
2015 Q2	$15.6M	Buy	+101,529	New	+$16.3M	0.8%	55

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Copeland Capital Management's AMGN Position: Q1 2026 in Review

Copeland Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 400 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #164.

Copeland Capital Management first reported a position in AMGN in Q2 2015 and has held it in 43 quarters since. The position peaked at $19.6M in Q3 2015. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Copeland Capital Management held 400 shares of Amgen worth $141K as of Q1 2026.
Copeland Capital Management left its Amgen share count unchanged in Q1 2026.
Amgen made up ﹤0.01% of Copeland Capital Management's portfolio in Q1 2026, its #164 holding.
Copeland Capital Management first reported a position in Amgen in Q2 2015 and has held it in 43 quarters since.
Copeland Capital Management's Amgen position peaked at $19.6M in Q3 2015.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Copeland Capital Management's 13F filing for Q1 2026, filed 6 May 2026.